The 30-10 rule of exome sequencing. Exome sequencing is likely to discover the cause in patients with presumed genetic neurodevelopmental disorders in ~30%. In ~10% of patients, this new diagnosis is likely to alter patient management.
Human exome sequencing at never before prices. More information available at http://www.genotypic.co.in/Genotypic-Specials/27/-Ion-Proton-TM-Sequencing-promotions-July-2013-Exome-Sequencing.aspx. To Avail the offer Register here with the promotional code PIPE7 http://www.genotypic.co.in/EnquiryForm.aspx?QT=F&=2=Ion-Proton-Exome-Sequencing